These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 31504324)

  • 1. Weight Gain Associated With Integrase Stand Transfer Inhibitor Use in Women.
    Kerchberger AM; Sheth AN; Angert CD; Mehta CC; Summers NA; Ofotokun I; Gustafson D; Weiser SD; Sharma A; Adimora AA; French AL; Augenbraun M; Cocohoba J; Kassaye S; Bolivar H; Govindarajulu U; Konkle-Parker D; Golub ET; Lahiri CD
    Clin Infect Dis; 2020 Jul; 71(3):593-600. PubMed ID: 31504324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Changes Associated With the Use of Integrase Strand Transfer Inhibitors Among Virally Controlled Women.
    Summers NA; Lahiri CD; Angert CD; Aldredge A; Mehta CC; Ofotokun I; Kerchberger AM; Gustafson D; Weiser SD; Kassaye S; Konkle-Parker D; Sharma A; Adimora AA; Bolivar H; Cocohoba J; French AL; Golub ET; Sheth AN
    J Acquir Immune Defic Syndr; 2020 Nov; 85(3):355-362. PubMed ID: 33060420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrase Strand Transfer Inhibitor Start or Switch Impacts Learning in Women With HIV.
    O'Halloran JA; Wang K; Spence AB; Williams DW; Dastgheyb R; Fitzgerald KC; Kamkwalala AR; Maki PM; Sharma A; Gustafson DR; Milam J; Weber KM; Adimora AA; Ofotokun I; Fischl MA; Konkle-Parker D; Lahiri CD; Sheth AN; Xu Y; Rubin LH
    J Acquir Immune Defic Syndr; 2021 Apr; 86(5):593-599. PubMed ID: 33394812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight and Body Mass Index Change After Switching to Integrase Inhibitors or Tenofovir Alafenamide Among Women Living with HIV.
    Lahiri CD; Xu Y; Wang K; Alvarez JA; Sheth AN; O'Halloran J; Spence AB; Tien P; Gustafson DR; Milam J; Fischl MA; Konkle-Parker D; Adimora AA; Sharma A; Weber KM; Ofotokun I; Rubin LH
    AIDS Res Hum Retroviruses; 2021 Jun; 37(6):461-467. PubMed ID: 33231474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consortium cohorts.
    Byonanebye DM; Polizzotto MN; Maltez F; Rauch A; Grabmeier-Pfistershammer K; Wit F; De Wit S; Castagna A; d'Arminio Monforte A; Mussini C; Wasmuth JC; Fontas E; Abela I; Sarcletti M; Bansi-Matharu L; Jaschinski N; Peters L; Hosein SR; Vannappagari V; Cohen C; Bissio E; Mocroft A; Law M; Ryom L; Petoumenos K;
    Lancet HIV; 2024 May; 11(5):e321-e332. PubMed ID: 38621392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generally rare but occasionally severe weight gain after switching to an integrase inhibitor in virally suppressed AGEhIV cohort participants.
    Verboeket SO; Boyd A; Wit FW; Verheij E; Schim van der Loeff MF; Kootstra N; van der Valk M; Reiss P;
    PLoS One; 2021; 16(5):e0251205. PubMed ID: 33951089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Energy balance and body composition after switch between integrase strand transfer inhibitors and doravirine among people with HIV.
    Erlandson KM; Mohaweche R; Morrow M; Mawhinney S; Khuu V; Boyd M; Balasubramanyam A; Melanson EL; Lake JE
    J Antimicrob Chemother; 2024 Jan; 79(1):179-185. PubMed ID: 38000089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity Modifies the Relationship Between Raltegravir and Dolutegravir Hair Concentrations and Body Weight Gain in Women Living with HIV.
    Lahiri CD; Mehta CC; Sykes C; Weiser SD; Palella F; Lake JE; Mellors JW; Gustafson D; French AL; Adimora AA; Konkle-Parker D; Sharma A; Bolivar H; Kassaye SG; Rubin LH; Alvarez JA; Golub ET; Ofotokun I; Sheth AN
    AIDS Res Hum Retroviruses; 2023 Dec; 39(12):644-651. PubMed ID: 37140468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors for Weight Gain Following Switch to Integrase Inhibitor-Based Antiretroviral Therapy.
    Lake JE; Wu K; Bares SH; Debroy P; Godfrey C; Koethe JR; McComsey GA; Palella FJ; Tassiopoulos K; Erlandson KM
    Clin Infect Dis; 2020 Dec; 71(9):e471-e477. PubMed ID: 32099991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world experience with weight gain among pregnant women living with HIV who are using integrase inhibitors.
    Fuller T; Fragoso da Silveira Gouvêa MI; Benamor Teixeira ML; Ferreira Medeiros A; Amorim da Silva P; Medeiros Braga C; Constan Werneck Sant'anna M; de Mattos Salgueiro M; da Silveira Bressan C; Mendes-Silva W; João EC
    HIV Med; 2023 Mar; 24(3):301-310. PubMed ID: 36065478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An assessment of weight change associated with the initiation of a protease or integrase strand transfer inhibitor in patients with human immunodeficiency virus.
    Chow W; Donga P; Côté-Sergent A; Rossi C; Lefebvre P; Lafeuille MH; Emond B; Hardy H
    Curr Med Res Opin; 2020 Aug; 36(8):1313-1323. PubMed ID: 32459155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial DNA haplogroups and weight gain following switch to integrase strand transfer inhibitor-based antiretroviral therapy.
    Erlandson KM; Wu K; Lake JE; Samuels DC; Bares SH; Tassiopoulos K; Koethe JR; Brown TT; Leonard M; Benson CA; Haas DW; Hulgan T;
    AIDS; 2021 Mar; 35(3):439-445. PubMed ID: 33252493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight Gain in Incarcerated Individuals Living With HIV After Switching to Integrase Strand Inhibitor-Based Therapy.
    Goldberg RN; Kania AT; Michienzi SM; Patel M; Badowski ME
    J Int Assoc Provid AIDS Care; 2021; 20():2325958221996860. PubMed ID: 33626965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight change with integrase strand transfer inhibitors among virally suppressed Thai people living with HIV.
    Han WM; Kerr SJ; Avihingsanon A; Boettiger DC
    J Antimicrob Chemother; 2022 Nov; 77(12):3242-3247. PubMed ID: 36101517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world weight changes in people with HIV-1 at risk of weight gain (female, Black or Hispanic) switching from integrase strand transfer inhibitors.
    Donga P; Emond B; Shah A; Bookhart BK; Anderson D; Vermette-Laforme M; Rossi C; Lafeuille MH
    J Comp Eff Res; 2023 Jan; 12(1):e220147. PubMed ID: 36445208
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiretroviral Therapy Anchor-based Trends in Body Mass Index Following Treatment Initiation Among Military Personnel with HIV.
    Kline MDA; Daniels C; Xu X; Sunil T; Ganesan A; Agan BK; Colombo RE; Kronmann KC; Blaylock JM; Okulicz JF; Markelz AE
    Mil Med; 2021 Feb; 186(3-4):279-285. PubMed ID: 33128552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrase Inhibitor Use Associated with Weight Gain in Women and Incident Diabetes Mellitus.
    Asundi A; Olson A; Jiang W; Varshney SP; White LF; Sagar M; Lin NH
    AIDS Res Hum Retroviruses; 2022 Mar; 38(3):208-215. PubMed ID: 34877881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of weight gain after antiretroviral switch to integrase strand transfer inhibitor or tenofovir alafenamide-based therapy.
    Sjaarda A; Bernstein A; Sparks A; Saber S; Siegel M
    Infection; 2022 Apr; 50(2):407-412. PubMed ID: 34449049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of integrase inhibitor use, body mass index, physical activity and caloric intake to weight gain in people living with HIV.
    Guaraldi G; Milic J; Bacchi E; Carli F; Menozzi M; Franconi I; Raimondi A; Ciusa G; Masi V; Belli M; Guaraldi S; Aprile E; Mancini M; Mussini C; Lake JE; Erlandson KM
    HIV Res Clin Pract; 2022 Nov; 24(1):1-6. PubMed ID: 36883678
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of a treatment switch to integrase Strand transfer inhibitor-based regimens on weight gain and other metabolic syndrome-related conditions.
    Maman O; Ahmad WA; Perzon O; Mahlab-Guri K; Elbirt D; Elinav H
    BMC Infect Dis; 2024 Feb; 24(1):221. PubMed ID: 38373940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.